April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Complications After Intravitreal Bevacizumab (Avastin): Analysis of 5132 Injections
D. Moreno-Paramo; A. Perez-Montesinos; R. Velez-Montoya; M. Martinez-Castellanos; G. Garcia-Aguirre; J. Dalma-Weiszhausz; J. Jimenez-Sierra; H. Quiroz-Mercado; D. Ochoa-Contreras; V. Morales-Canton
Author Affiliations & Notes
  • D. Moreno-Paramo
    Retina, APEC, Mexico, Mexico
  • A. Perez-Montesinos
    Retina, APEC, Mexico, Mexico
  • R. Velez-Montoya
    Retina, APEC, Mexico, Mexico
  • M. Martinez-Castellanos
    Retina, APEC, Mexico, Mexico
  • G. Garcia-Aguirre
    Retina, APEC, Mexico, Mexico
  • J. Dalma-Weiszhausz
    Retina, APEC, Mexico, Mexico
  • J. Jimenez-Sierra
    Retina, APEC, Mexico, Mexico
  • H. Quiroz-Mercado
    Retina, APEC, Mexico, Mexico
  • D. Ochoa-Contreras
    Retina, APEC, Mexico, Mexico
  • V. Morales-Canton
    Retina, APEC, Mexico, Mexico
  • Footnotes
    Commercial Relationships  D. Moreno-Paramo, None; A. Perez-Montesinos, None; R. Velez-Montoya, None; M. Martinez-Castellanos, None; G. Garcia-Aguirre, None; J. Dalma-Weiszhausz, None; J. Jimenez-Sierra, None; H. Quiroz-Mercado, None; D. Ochoa-Contreras, None; V. Morales-Canton, None.
  • Footnotes
    Support  APEC
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 45. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Complications After Intravitreal Bevacizumab (Avastin): Analysis of 5132 Injections
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      D. Moreno-Paramo, A. Perez-Montesinos, R. Velez-Montoya, M. Martinez-Castellanos, G. Garcia-Aguirre, J. Dalma-Weiszhausz, J. Jimenez-Sierra, H. Quiroz-Mercado, D. Ochoa-Contreras, V. Morales-Canton; Complications After Intravitreal Bevacizumab (Avastin): Analysis of 5132 Injections. Invest. Ophthalmol. Vis. Sci. 2009;50(13):45.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: : To assess the ocular and systemic complications after intravitreal injection of 2.5mg of Bevacizumab (Avastin).

Methods: : We retrospectively reviewed 5132 cases of intravitreal injections of Bevacizumab (Avastin), 2.5 mg/0.1 ml within a 3 year period in the Retina Service of Asociación para Evitar la Ceguera en Mexico.

Results: : Six eyes (0.11%) with proliferative diabetic retinopathy developed tractional retinal detachment. Seven eyes (0.13%) developed infectious endophtalmitis; one eye presented a rhegmatogenuos retinal detachment (0.01%), 3 vitreous hemorrhage (0.05%) and leakage of vitreous in 3 patients (0.05%).

Conclusions: : Intravitreal injection of bevacizumab seems to be a low risk procedure with a minimal rate of ocular complications.

Keywords: retina • retinal neovascularization • neovascularization 
© 2009, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept